LifeVantage Corporation(LFVN)Earnings, Financials & Key Ratios

LFVN•NASDAQ

$6.00

$77M mkt cap·7.9× P/E·Price updated May 6, 2026

SectorConsumer Defensive IndustryPackaged Foods Sub-IndustryNutrition and functional foods

AboutLifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.Show more

Revenue$229M+14.2%
EBITDA$15M+94.0%
Net Income$10M+233.8%
EPS (Diluted)0.76+230.4%
Gross Margin80.37%+1.4%
EBITDA Margin6.72%+70.0%
Operating Margin5.34%+146.7%
Net Margin4.29%+192.4%
ROE32.34%+233.9%
ROIC37.47%+181.7%
Debt/Equity0.34-35.6%

Technical→

LFVN Key Insights

LifeVantage Corporation (LFVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Good 3Y average ROE of 16.6%
✓Healthy dividend yield of 2.7%
✓Efficient asset utilization: 3.2x turnover

✗Weaknesses

✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

LFVN Price & Volume

LifeVantage Corporation (LFVN) stock price & volume — 10-year historical chart

Loading chart...

LFVN Growth Metrics

LifeVantage Corporation (LFVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.85%

5 Years-0.38%

3 Years3.46%

TTM-12.15%

Profit CAGR

10 Years3.45%

5 Years-3.22%

3 Years46.48%

TTM-37.14%

EPS CAGR

10 Years4.49%

5 Years-0.77%

3 Years46.85%

TTM-34.54%

Return on Capital

10 Years32.29%

5 Years20.95%

3 Years16.35%

Last Year29.49%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
NATRNature's Sunshine Products, Inc.Direct Competitor	459.31M	26.24	24.75	5.67%	4.07%	11.85%	0.12
NHTCNatural Health Trends Corp.Direct Competitor	34.6M	3.10	-40.42	-7.42%	-3.03%	-4.88%	0.13
QNSTQuinStreet, Inc.Direct Competitor	742.06M	13.02	161.34	78.27%	5.64%	24.45%	0.04
HLFHerbalife Nutrition Ltd.Product Competitor	1.7B	16.44	7.47	0.89%	4.67%
USNAUSANA Health Sciences, Inc.Product Competitor	369.32M	20.01	34.50	8.28%	1.16%	1.84%	0.02
NUSNu Skin Enterprises, Inc.Product Competitor	353.79M	7.34	2.31	-14.26%	7.02%	13.7%	0.35
PLBYPlayboy, Inc.Product Competitor	189.54M	1.68	-12.92	4.13%	-10.48%	-247.79%	1.30
MGICMagic Software Enterprises Ltd.Product Competitor	853.35M	17.38	23.17	3.26%	6.64%	13.38%	0.29

Compare LFVN vs Peers

LifeVantage Corporation (LFVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NATR

Most directly comparable listed peer for LFVN.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare LFVN against a more recognizable public peer.

Peer Set

Compare Top 5

vs NATR, NHTC, QNST, HLF

LFVN Income Statement

LifeVantage Corporation (LFVN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Sales/Revenue	199.49M	203.2M	225.96M	232.91M	220.18M	206.36M	213.4M	200.16M	228.53M	195.32M
Revenue Growth %	-3.41%	1.86%	11.2%	3.08%	-5.47%	-6.28%	3.41%	-6.2%	14.17%	-12.15%
Cost of Goods Sold	33.46M	34.85M	37.97M	37.96M	38.19M	38.1M	43.39M	41.44M	44.86M	42.7M
COGS % of Revenue	16.77%	17.15%	16.81%	16.3%	17.34%	18.46%	20.33%	20.7%	19.63%	-
Gross Profit	166.03M▲ 0%	168.36M▲ 1.4%	187.99M▲ 11.7%	194.95M▲ 3.7%	181.99M▼ 6.6%	168.26M▼ 7.5%	170.01M▲ 1.0%	158.72M▼ 6.6%	183.67M▲ 15.7%	152.62M▲ 0%
Gross Margin %	83.23%	82.85%	83.19%	83.7%	82.66%	81.54%	79.67%	79.3%	80.37%	78.14%
Gross Profit Growth %	-3.81%	1.4%	11.66%	3.71%	-6.65%	-7.54%	1.04%	-6.64%	15.71%	-
Operating Expenses	161.58M	158.03M	178.17M	179.49M	164.38M	160.69M	165.75M	154.39M	171.47M	136.87M
OpEx % of Revenue	81%	77.77%	78.85%	77.06%	74.66%	77.87%	77.67%	77.13%	75.03%	-
Selling, General & Admin	161.58M	158.03M	178.17M	179.49M	164.38M	63.42M	71.06M	68.47M	69.21M	63.22M
SG&A % of Revenue	81%	77.77%	78.85%	77.06%	74.66%	30.74%	33.3%	34.21%	30.28%	-
Research & Development	1.1M	1.2M	1.1M	0	700K	0	0	0	0	0
R&D % of Revenue	0.55%	0.59%	0.49%	-	0.32%	-	-	-	-	-
Other Operating Expenses	-969K	-319K	-261K	0	-700K	97.26M	94.69M	85.92M	102.26M	4M
Operating Income	4.45M▲ 0%	10.32M▲ 132.0%	9.49M▼ 8.1%	15.47M▲ 63.0%	17.61M▲ 13.9%	7.58M▼ 57.0%	4.26M▼ 43.8%	4.33M▲ 1.7%	12.2M▲ 181.6%	6.58M▲ 0%
Operating Margin %	2.23%	5.08%	4.2%	6.64%	8%	3.67%	2%	2.16%	5.34%	3.37%
Operating Income Growth %	-66.83%	132.03%	-8.06%	62.95%	13.89%	-57%	-43.78%	1.71%	181.6%	-
EBITDA	6.09M	11.65M	11.39M	20.57M	21.07M	10.84M	7.84M	7.91M	15.36M	8.69M
EBITDA Margin %	3.05%	5.73%	5.04%	8.83%	9.57%	5.25%	3.67%	3.95%	6.72%	4.45%
EBITDA Growth %	-60.21%	91.2%	-2.25%	80.63%	2.48%	-48.58%	-27.67%	0.96%	94.05%	-46.25%
D&A (Non-Cash Add-back)	1.64M	1.32M	1.9M	5.1M	3.46M	3.26M	3.58M	3.58M	3.16M	2.11M
EBIT	3.48M	10M	9.55M	14.78M	17.61M	4.7M	4.26M	4.33M	12.2M	4.9M
Net Interest Income	-570K	-456K	-323K	-120K	-17K	-10K	198K	430K	431K	218K
Interest Income	0	0	0	0	0	0	198K	430K	431K	218K
Interest Expense	570K	456K	323K	120K	17K	10K	0	0	0	0
Other Income/Expense	-1.54M	-775K	-584K	-805K	-383K	-2.88M	-260K	18K	44K	185K
Pretax Income	2.91M▲ 0%	9.55M▲ 228.1%	9.23M▼ 3.3%	14.66M▲ 58.8%	17.23M▲ 17.5%	4.69M▼ 72.8%	4M▼ 14.8%	4.35M▲ 8.8%	12.24M▲ 181.4%	6.77M▲ 0%
Pretax Margin %	1.46%	4.7%	4.08%	6.29%	7.83%	2.27%	1.87%	2.17%	5.36%	3.46%
Income Tax	1.3M	3.79M	1.8M	3.11M	4.34M	1.57M	1.46M	1.41M	2.44M	426K
Effective Tax Rate %	44.74%	39.66%	19.51%	21.23%	25.17%	33.49%	36.48%	32.48%	19.91%	6.3%
Net Income	1.61M▲ 0%	5.76M▲ 258.3%	7.43M▲ 29.0%	11.55M▲ 55.5%	12.89M▲ 11.6%	3.12M▼ 75.8%	2.54M▼ 18.6%	2.94M▲ 15.6%	9.8M▲ 233.8%	5.75M▲ 0%
Net Margin %	0.81%	2.84%	3.29%	4.96%	5.86%	1.51%	1.19%	1.47%	4.29%	2.94%
Net Income Growth %	-73.28%	258.27%	28.95%	55.46%	11.65%	-75.8%	-18.59%	15.63%	233.84%	-37.14%
Net Income (Continuing)	1.61M	5.76M	7.43M	11.55M	12.89M	3.12M	2.54M	2.94M	9.8M	5.75M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.11▲ 0%	0.41▲ 272.7%	0.50▲ 22.0%	0.79▲ 58.0%	0.90▲ 13.9%	0.24▼ 73.3%	0.20▼ 16.7%	0.23▲ 15.0%	0.76▲ 230.4%	0.45▲ 0%
EPS Growth %	-73.17%	272.73%	21.95%	58%	13.92%	-73.33%	-16.67%	15%	230.43%	-34.54%
EPS (Basic)	0.12	0.41	0.53	0.82	0.92	0.24	0.20	0.24	0.80	-
Diluted Shares Outstanding	14.12M	14.14M	14.98M	14.6M	14.27M	13.07M	12.57M	12.99M	12.99M	12.66M
Basic Shares Outstanding	13.88M	13.99M	14.05M	14.11M	14.07M	12.89M	12.56M	12.46M	12.25M	12.63M
Dividend Payout Ratio	-	-	-	-	2.93%	12.12%	62.44%	236.3%	21.08%	-

LFVN Balance Sheet

LifeVantage Corporation (LFVN) balance sheet — assets, liabilities & shareholders' equity

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Total Current Assets	35.55M	38.94M	43.19M	43.87M	48.05M	46.96M	44.28M	37.65M	50.89M	39.31M
Cash & Short-Term Investments	11.46M	16.65M	18.82M	22.14M	23.17M	20.19M	21.61M	16.89M	20.2M	12.48M
Cash Only	11.46M	16.65M	18.82M	22.14M	23.17M	20.19M	21.61M	16.89M	20.2M	12.48M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.25M	2.52M	3.3M	2.61M	3.96M	5.09M	1.85M	3.26M	3.93M	2.42M
Days Sales Outstanding	4.11	4.52	5.33	4.09	6.57	9	3.17	5.95	6.28	8.04
Inventory	16.57M	13.63M	13.75M	13.89M	16.14M	16.47M	16.07M	15.05M	20.67M	18.38M
Days Inventory Outstanding	180.83	142.73	132.2	133.52	154.32	157.82	135.22	132.6	168.16	161.16
Other Current Assets	0	0	0	0	0	0	4.75M	2.44M	6.09M	6.03M
Total Non-Current Assets	9.7M	12.2M	12.09M	15.01M	30.68M	23.75M	21.84M	22.65M	21.06M	22.81M
Property, Plant & Equipment	3.13M	6.59M	7.13M	8.13M	24.82M	20.54M	17.82M	17.38M	14.25M	13.76M
Fixed Asset Turnover	63.80x	30.85x	31.69x	28.66x	8.87x	10.05x	11.97x	11.52x	16.04x	13.67x
Goodwill	0	0	0	0	0	0	0	0	0	472K
Intangible Assets	1.25M	1.11M	983K	851K	719K	587K	455K	323K	245K	3.19M
Long-Term Investments	0	0	0	2.21M	2.21M	0	0	0	0	0
Other Non-Current Assets	1.24M	1.25M	1.28M	1.66M	1.72M	1.33M	569K	680K	601K	2.48M
Total Assets	45.25M▲ 0%	51.14M▲ 13.0%	55.27M▲ 8.1%	58.88M▲ 6.5%	78.73M▲ 33.7%	70.71M▼ 10.2%	66.12M▼ 6.5%	60.3M▼ 8.8%	71.96M▲ 19.3%	62.13M▲ 0%
Asset Turnover	4.41x	3.97x	4.09x	3.96x	2.80x	2.92x	3.23x	3.32x	3.18x	3.08x
Asset Growth %	-9.97%	13.02%	8.08%	6.52%	33.72%	-10.19%	-6.48%	-8.81%	19.34%	4.03%
Total Current Liabilities	23.36M	23.8M	26.2M	25.02M	25.2M	25.73M	19.61M	22.31M	27.22M	20.1M
Accounts Payable	4.85M	3.81M	5.18M	4.61M	7.59M	7.92M	4.22M	6.29M	5.06M	5.15M
Days Payables Outstanding	52.91	39.94	49.79	44.33	72.56	75.91	35.54	55.38	41.16	43.06
Short-Term Debt	2M	2M	1.45M	0	0	0	0	0	0	1.89M
Deferred Revenue (Current)	1.74M	1.11M	998K	792K	319K	78K	834K	860K	711K	0
Other Current Liabilities	12.2M	11.52M	1.06M	4.55M	1.5M	971K	3.1M	1.61M	5.33M	18.22M
Current Ratio	1.52x	1.64x	1.65x	1.75x	1.91x	1.83x	2.26x	1.69x	1.87x	1.87x
Quick Ratio	0.81x	1.06x	1.12x	1.20x	1.27x	1.18x	1.44x	1.01x	1.11x	1.11x
Cash Conversion Cycle	132.03	107.32	87.74	93.28	88.33	90.91	102.84	83.18	133.27	126.14
Total Non-Current Liabilities	7.37M	5.39M	1.88M	604K	16.73M	13.46M	11.87M	12M	10.1M	8.69M
Long-Term Debt	5.44M	3.41M	0	0	0	0	0	0	0	8.32M
Capital Lease Obligations	0	0	0	0	16.03M	13.15M	11.57M	11.8M	9.81M	28.99M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1.93M	1.98M	1.88M	604K	694K	308K	299K	198K	289K	1.22M
Total Liabilities	30.72M	29.2M	28.07M	25.62M	41.92M	39.19M	31.47M	34.31M	37.32M	28.79M
Total Debt	7.44M	5.41M	1.45M	1.18M	18.18M	15.76M	13.09M	13.61M	11.68M	10.21M
Net Debt	-4.02M	-11.24M	-17.37M	-20.95M	-4.99M	-4.43M	-8.52M	-3.27M	-8.52M	-2.28M
Debt / Equity	0.51x	0.25x	0.05x	0.04x	0.49x	0.50x	0.38x	0.52x	0.34x	0.34x
Debt / EBITDA	1.22x	0.46x	0.13x	0.06x	0.86x	1.45x	1.67x	1.72x	0.76x	1.17x
Net Debt / EBITDA	-0.66x	-0.96x	-1.53x	-1.02x	-0.24x	-0.41x	-1.09x	-0.41x	-0.56x	-0.56x
Interest Coverage	6.11x	21.94x	29.58x	123.18x	1036.18x	470.10x	-	-	-	-
Total Equity	14.53M▲ 0%	21.95M▲ 51.1%	27.2M▲ 23.9%	33.25M▲ 22.3%	36.81M▲ 10.7%	31.52M▼ 14.4%	34.65M▲ 9.9%	25.99M▼ 25.0%	34.64M▲ 33.3%	33.34M▲ 0%
Equity Growth %	19.75%	51.08%	23.93%	22.26%	10.68%	-14.37%	9.94%	-24.99%	33.28%	65.35%
Book Value per Share	1.03	1.55	1.82	2.28	2.58	2.41	2.76	2.00	2.67	2.63
Total Shareholders' Equity	14.53M	21.95M	27.2M	33.25M	36.81M	31.52M	34.65M	25.99M	34.64M	33.34M
Common Stock	14K	1K	1K	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-106.99M	-102.73M	-99.96M	-93.31M	-92.35M	-98.44M	-98.31M	-108.74M	-104.15M	-103.66M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-94K	14K	62K	144K	104K	-1.12M	-1.36M	-1.92M	-1.18M	-1.73M
Minority Interest	0	0	0	0	0	0	0	0	0	0

LFVN Cash Flow Statement

LifeVantage Corporation (LFVN) cash flow — operating, investing & free cash flow history

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Cash from Operations	6.6M	13.26M	17.79M	18.33M	7.96M	7.96M	6.83M	12.2M	11.88M	11.88M
Operating CF Margin %	3.31%	6.52%	7.87%	7.87%	3.61%	3.86%	3.2%	6.09%	5.2%	-
Operating CF Growth %	9.29%	100.94%	34.2%	3.02%	-56.57%	0%	-14.21%	78.63%	-2.62%	-301.1%
Net Income	1.61M	5.76M	7.43M	11.55M	3.12M	3.12M	2.54M	2.94M	9.8M	5.75M
Depreciation & Amortization	1.64M	1.32M	1.9M	5.1M	3.26M	3.26M	3.58M	3.58M	3.16M	2.83M
Stock-Based Compensation	2.65M	3.2M	5.53M	4.92M	1.77M	1.77M	3.19M	3.28M	5.7M	3.63M
Deferred Taxes	-740K	831K	563K	364K	-81K	-81K	-1.7M	-1.28M	-1.7M	2.13M
Other Non-Cash Items	381K	32K	42K	46K	3.99M	3.99M	1.78M	1.3M	1.47M	-3.31M
Working Capital Changes	1.06M	2.11M	2.33M	-3.65M	-4.1M	-4.1M	-2.56M	2.38M	-6.55M	-4.51M
Change in Receivables	-752K	-268K	-771K	698K	-1.33M	-1.33M	3.07M	-1.5M	-564K	152K
Change in Inventory	8.31M	2.95M	-64K	-152K	-1.19M	-1.19M	61K	662K	-5.22M	4.5M
Change in Payables	-6.21M	-1.02M	1.37M	-1.65M	824K	824K	-3.98M	2.3M	-1.29M	-1.89M
Cash from Investing	-1.05M	-4.65M	-4.51M	-2.68M	-1.53M	-1.53M	-3.06M	-2.25M	-1.37M	-6.48M
Capital Expenditures	-1.05M	-4.65M	-2.51M	-2.68M	-1.53M	-1.53M	-3.07M	-2.25M	-1.37M	-2.73M
CapEx % of Revenue	0.53%	2.29%	1.11%	1.15%	0.69%	0.74%	1.44%	1.12%	0.6%	-
Acquisitions	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-2M	0	0	0	8K	0	4K	-3.74M
Cash from Financing	-1.96M	-3.5M	-11.12M	-12.42M	-8.95M	-8.95M	-2.36M	-14.42M	-7.6M	-9.88M
Debt Issued (Net)	-2M	-2M	-4M	-1.5M	0	0	0	0	0	0
Equity Issued (Net)	0	-1.5M	-7.82M	-11.65M	-9.08M	-8.57M	-771K	-7.38M	-5.53M	-8.57M
Dividends Paid	0	0	0	0	-378K	-378K	-1.59M	-6.94M	-2.07M	-2.28M
Share Repurchases	0	-1.5M	-7.82M	-11.65M	-9.08M	-9.08M	-1.02M	-7.65M	-5.81M	-6.28M
Other Financing	42K	1K	701K	729K	505K	0	0	-97K	0	979K
Net Change in Cash	3.58M▲ 0%	5.19M▲ 45.3%	2.17M▼ 58.2%	3.31M▲ 52.6%	-2.98M▼ 190.0%	-2.98M▲ 0.0%	1.42M▲ 147.4%	-4.72M▼ 433.5%	3.31M▲ 170.2%	-9.99M▲ 0%
Free Cash Flow	5.54M▲ 0%	8.61M▲ 55.3%	15.28M▲ 77.6%	15.64M▲ 2.4%	6.43M▼ 58.9%	6.43M▲ 0.0%	3.76M▼ 41.5%	9.95M▲ 164.6%	10.51M▲ 5.6%	3.77M▲ 0%
FCF Margin %	2.78%	4.24%	6.76%	6.72%	2.92%	3.12%	1.76%	4.97%	4.6%	1.93%
FCF Growth %	1.24%	55.3%	77.56%	2.37%	-58.91%	0%	-41.5%	164.61%	5.58%	-68.48%
FCF per Share	0.39	0.61	1.02	1.07	0.45	0.49	0.30	0.77	0.81	0.81
FCF Conversion (FCF/Net Income)	4.10x	2.30x	2.39x	1.59x	0.62x	2.55x	2.69x	4.15x	1.21x	0.66x
Interest Paid	438K	345K	227K	44K	0	0	5K	21K	2K	9K
Taxes Paid	5.5M	2.87M	1.29M	1.62M	0	0	1.87M	2.31M	4.92M	2.2M

LFVN Key Ratios

LifeVantage Corporation (LFVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	12.06%	31.59%	30.23%	38.21%	36.81%	9.13%	7.68%	9.69%	32.34%	17.78%
Return on Invested Capital (ROIC)	27.62%	72.98%	69.32%	104.84%	59.89%	19.29%	12.01%	13.3%	37.47%	37.47%
Gross Margin	83.23%	82.85%	83.19%	83.7%	82.66%	81.54%	79.67%	79.3%	80.37%	78.14%
Net Margin	0.81%	2.84%	3.29%	4.96%	5.86%	1.51%	1.19%	1.47%	4.29%	2.94%
Debt / Equity	0.51x	0.25x	0.05x	0.04x	0.49x	0.50x	0.38x	0.52x	0.34x	0.34x
Interest Coverage	6.11x	21.94x	29.58x	123.18x	1036.18x	470.10x	-	-	-	-
FCF Conversion	4.10x	2.30x	2.39x	1.59x	0.62x	2.55x	2.69x	4.15x	1.21x	0.66x
Revenue Growth	-3.41%	1.86%	11.2%	3.08%	-5.47%	-6.28%	3.41%	-6.2%	14.17%	-12.15%

LFVN SEC Filings & Documents

LifeVantage Corporation (LFVN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 6, 2026·SEC

Material company update

Apr 16, 2026·SEC

Material company update

Feb 4, 2026·SEC

10-K Annual Reports

FY 2025

Sep 4, 2025·SEC

FY 2024

Aug 28, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2026

Feb 4, 2026·SEC

FY 2025

Nov 4, 2025·SEC

LFVN Frequently Asked Questions

LifeVantage Corporation (LFVN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

LifeVantage Corporation (LFVN) reported $195.3M in revenue for fiscal year 2025.

LifeVantage Corporation (LFVN) grew revenue by 14.2% over the past year. This is steady growth.

Yes, LifeVantage Corporation (LFVN) is profitable, generating $5.8M in net income for fiscal year 2025 (4.3% net margin).

Dividend & Returns

Yes, LifeVantage Corporation (LFVN) pays a dividend with a yield of 2.65%. This makes it attractive for income-focused investors.

LifeVantage Corporation (LFVN) has a return on equity (ROE) of 32.3%. This is excellent, indicating efficient use of shareholder capital.

LifeVantage Corporation (LFVN) generated $3.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More LFVN

LifeVantage Corporation (LFVN) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

LifeVantage Corporation(LFVN)Earnings, Financials & Key Ratios

LFVN Key Insights

✓Strengths

✗Weaknesses

LFVN Price & Volume

LFVN Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

LFVN Peer Comparison

Compare LFVN vs Peers

vs NATR

vs AMZN

Compare Top 5

LFVN Income Statement

LFVN Balance Sheet

LFVN Cash Flow Statement

LFVN Key Ratios

LFVN SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

LFVN Frequently Asked Questions

Explore More LFVN

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation